CN106110334B - 一种表面功能化可载药洗脱微球的制备方法 - Google Patents

一种表面功能化可载药洗脱微球的制备方法 Download PDF

Info

Publication number
CN106110334B
CN106110334B CN201610650166.7A CN201610650166A CN106110334B CN 106110334 B CN106110334 B CN 106110334B CN 201610650166 A CN201610650166 A CN 201610650166A CN 106110334 B CN106110334 B CN 106110334B
Authority
CN
China
Prior art keywords
carboxymethyl chitosan
microballoon
microsphere
preparation
carried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610650166.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN106110334A (zh
Inventor
倪才华
曹元龙
石刚
张丽萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changsha Jingyi Pharmaceutical Technology Co ltd
Hefei Guiqian Information Technology Co ltd
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201610650166.7A priority Critical patent/CN106110334B/zh
Priority to KR1020187007546A priority patent/KR102083023B1/ko
Priority to PCT/CN2016/104511 priority patent/WO2018028058A1/zh
Publication of CN106110334A publication Critical patent/CN106110334A/zh
Application granted granted Critical
Publication of CN106110334B publication Critical patent/CN106110334B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201610650166.7A 2016-08-08 2016-08-08 一种表面功能化可载药洗脱微球的制备方法 Active CN106110334B (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201610650166.7A CN106110334B (zh) 2016-08-08 2016-08-08 一种表面功能化可载药洗脱微球的制备方法
KR1020187007546A KR102083023B1 (ko) 2016-08-08 2016-11-04 표면 기능화된 약물 운반 가능한 용출 마이크로스피어의 제조 방법
PCT/CN2016/104511 WO2018028058A1 (zh) 2016-08-08 2016-11-04 一种表面功能化可载药洗脱微球的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610650166.7A CN106110334B (zh) 2016-08-08 2016-08-08 一种表面功能化可载药洗脱微球的制备方法

Publications (2)

Publication Number Publication Date
CN106110334A CN106110334A (zh) 2016-11-16
CN106110334B true CN106110334B (zh) 2019-11-15

Family

ID=57257628

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610650166.7A Active CN106110334B (zh) 2016-08-08 2016-08-08 一种表面功能化可载药洗脱微球的制备方法

Country Status (3)

Country Link
KR (1) KR102083023B1 (ko)
CN (1) CN106110334B (ko)
WO (1) WO2018028058A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108264612B (zh) * 2018-02-25 2020-10-09 温岭汉德高分子科技有限公司 一种用于单晶硅制绒的壳聚糖-聚2-丙烯酰胺基-2-甲基丙磺酸钠共聚物的制备方法
CN109464702B (zh) * 2019-01-14 2021-02-26 浙江瑞谷生物科技有限公司 含bmp-2的牙槽骨修复材料及其制备方法和应用
DE102019107633A1 (de) 2019-03-25 2020-10-29 Sphera Technology Gmbh Mehrkomponentensystem und Verfahren zur Herstellung eines Mehrkomponentensystems
CN110508259B (zh) * 2019-09-03 2022-02-15 晋江瑞碧科技有限公司 一种铜离子印迹复合磁性中空微球的制备方法
CN112168787B (zh) * 2020-09-24 2023-03-24 山东瑞安泰医疗技术有限公司 一种功能化可降解药物洗脱微球及其制备方法
DE102020124955A1 (de) 2020-09-24 2022-03-24 Sphera Technology Gmbh Elektronikeinheit mit einem integrierten Schaltkreis und Verfahren zu deren Herstellung
CN112316199B (zh) * 2020-11-16 2022-02-22 江南大学 一种改性羧甲基壳聚糖微球及其制备方法和应用
CN114191410A (zh) * 2021-11-15 2022-03-18 深圳北航新兴产业技术研究院 一种诊疗一体化双亲微球缓释微球的制备方法
CN114481616A (zh) * 2022-03-11 2022-05-13 四川三联新材料有限公司 一种加热卷烟用壳聚糖基膜复合材料的制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103304417A (zh) * 2012-03-15 2013-09-18 江南大学 一种双亲性共聚物改性壳聚糖复合物的制备及应用
CN103977458A (zh) * 2014-05-28 2014-08-13 南京弗来明医疗器械有限公司 多羟基聚合体栓塞微球及其制备工艺
CN104258474A (zh) * 2014-10-15 2015-01-07 江南大学 一种含有离子交换功能基团的栓塞微球
CN104338185A (zh) * 2014-11-06 2015-02-11 石家庄亿生堂医用品有限公司 一种羧甲基壳聚糖微球栓塞剂及其制备方法
CN105273209A (zh) * 2014-06-09 2016-01-27 江南大学 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备
CN107321326A (zh) * 2017-07-03 2017-11-07 重庆大学 阴离子聚合物接枝壳聚糖磁性复合微球及制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101125225A (zh) * 2007-08-10 2008-02-20 苏州迦俐生生物医药科技有限公司 微球型栓塞剂及其制备工艺
CN101775386A (zh) * 2010-01-26 2010-07-14 武汉工业学院 一种壳聚糖微球固定化胰蛋白酶的方法
CN102462664A (zh) * 2010-11-18 2012-05-23 华侨大学 一种磺酸基巯基壳聚糖介入栓塞化疗缓释微球及其制备方法
CN102784112B (zh) 2011-05-19 2014-08-06 东华理工大学 壳聚糖接枝共聚物多孔缓释微球的制备方法
CN103965403A (zh) * 2013-01-24 2014-08-06 孙亮 壳聚糖接枝amps的新方法
CN104208756A (zh) * 2014-08-29 2014-12-17 石家庄亿生堂医用品有限公司 一种羧甲基壳聚糖微球的制备方法
CN104474575B (zh) * 2014-12-03 2017-06-30 广州肽莱医药科技有限公司 共价交联形成的壳聚糖止血材料及其制备方法
CN104548123B (zh) * 2014-12-11 2017-10-10 江南大学 一种酰化改性明胶栓塞微球的制备

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103304417A (zh) * 2012-03-15 2013-09-18 江南大学 一种双亲性共聚物改性壳聚糖复合物的制备及应用
CN103977458A (zh) * 2014-05-28 2014-08-13 南京弗来明医疗器械有限公司 多羟基聚合体栓塞微球及其制备工艺
CN105273209A (zh) * 2014-06-09 2016-01-27 江南大学 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备
CN104258474A (zh) * 2014-10-15 2015-01-07 江南大学 一种含有离子交换功能基团的栓塞微球
CN104258474B (zh) * 2014-10-15 2015-09-23 江南大学 一种含有离子交换功能基团的栓塞微球及其制备方法
CN104338185A (zh) * 2014-11-06 2015-02-11 石家庄亿生堂医用品有限公司 一种羧甲基壳聚糖微球栓塞剂及其制备方法
CN107321326A (zh) * 2017-07-03 2017-11-07 重庆大学 阴离子聚合物接枝壳聚糖磁性复合微球及制备方法和应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"动脉栓塞微球的研究进展";侯志勇等;《中国医药科学》;20120831;第2卷(第16期);第9-11页 *
"表面改性羧甲基壳聚糖栓塞微球的制备及性能研究";曹元龙等;《化工新型材料》;20180131;第46卷(第1期);第214-222页 *
"载药栓塞微球的制备及控释性能研究";张猛;《中国优秀硕士学位论文全文数据库工程科技Ⅰ辑》;20150115(第1期);第33页3.2.3壳聚糖微球的合成方法；第32页3.1引言第1-2段，第35页3.2.7CS/PAMPS复合微球的合成方法 *

Also Published As

Publication number Publication date
KR20180057622A (ko) 2018-05-30
WO2018028058A1 (zh) 2018-02-15
CN106110334A (zh) 2016-11-16
KR102083023B1 (ko) 2020-02-28

Similar Documents

Publication Publication Date Title
CN106110334B (zh) 一种表面功能化可载药洗脱微球的制备方法
CN105816920A (zh) 一种改性海藻酸钠栓塞微球的制备方法
CN104530415B (zh) 一种异官能化y型聚乙二醇衍生物、制备方法及其生物相关物质
CN106693040A (zh) 一种可载药聚乙烯醇洗脱微球的制备方法
Mu et al. Unsaturated nitrogen-rich polymer poly (l-histidine) gated reversibly switchable mesoporous silica nanoparticles using “graft to” strategy for drug controlled release
CN108144067B (zh) 四价铂化合物-双环双键两亲性聚合物前药、其纳米胶束及制备方法和应用
Zhang et al. Supramolecular hydrogels co-loaded with camptothecin and doxorubicin for sustainedly synergistic tumor therapy
Yi et al. Synthesis, characterization, and formulation of poly-puerarin as a biodegradable and biosafe drug delivery platform for anti-cancer therapy
CN111603568A (zh) 电荷反转型聚肽复合纳米药物及其制备方法和应用
Han et al. A pH‐responsive carboxymethyl dextran‐based conjugate as a carrier of docetaxel for cancer therapy
Xie et al. Targeted nanoparticles from xyloglucan–doxorubicin conjugate loaded with doxorubicin against drug resistance
CN108853515A (zh) 短肽水凝胶的制备方法及应用、药物组合物
Zeng et al. Hyaluronic acid mediated biomineralization of multifunctional ceria nanocomposites as ROS scavengers and tumor photodynamic therapy agents
Chen et al. A biomimicking and electrostatic self-assembly strategy for the preparation of glycopolymer decorated photoactive nanoparticles
CN104666247A (zh) 肝素修饰的可断键阿霉素脂质体制剂及其制备方法
CN101653611A (zh) 一种白蛋白-阿霉素纳米制剂及其制备方法和应用
CN104761732B (zh) 一种肿瘤细胞靶向的纳米凝胶及其制备方法以及一种肿瘤细胞靶向的纳米凝胶载药颗粒
CN110511387A (zh) 透明质酸-g-聚酪氨酸-硫辛酸共聚物、聚多肽纳米粒及其制备方法与应用
CN112661961B (zh) 两亲性聚噁唑啉共聚物、其制备方法及应用
CN115737895A (zh) 一种用于抗肝癌的磁性栓塞微球及其制备方法与应用
CN115845059A (zh) 一种基于聚氨基酸的小分子抑制剂纳米粒及其制备方法与应用
KR102253745B1 (ko) 광역동 치료용 이리듐 복합체의 담지를 위한 나노젤
CN102327615B (zh) 一种骨靶向载体和药物
CN110339368B (zh) 还原响应的靶向聚乙二醇-聚碳酸酯美登素前药胶束的制备方法
CN105797169A (zh) 一种抗肿瘤大分子前药复合物及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20230329

Address after: Room 403, Building 2, Laojie Library, Dianbu Town, Feidong County, Hefei City, Anhui Province, 231699

Patentee after: Hefei guiqian Information Technology Co.,Ltd.

Address before: No. 1800 road 214122 Jiangsu Lihu Binhu District City of Wuxi Province

Patentee before: Jiangnan University

Effective date of registration: 20230329

Address after: Room 801, 8th Floor, Building A-3, Jinrui Lugu Science Park, No. 28, Lutian Road, Changsha High tech Development Zone, Changsha City, Hunan Province, 410221

Patentee after: Changsha Jingyi Pharmaceutical Technology Co.,Ltd.

Address before: Room 403, Building 2, Laojie Library, Dianbu Town, Feidong County, Hefei City, Anhui Province, 231699

Patentee before: Hefei guiqian Information Technology Co.,Ltd.

TR01 Transfer of patent right